Roundtable: Pediatric ophthalmologists address difficulties of treating myopia progression with atropine

Myopia progression is a hot topic in pediatric ophthalmology, whether the treating physician uses atropine, surgical procedures or contact lenses.
The dilemma for pediatric ophthalmologists is whether to offer an off-label treatment, atropine drops, to inhibit axial lengthening when questions remain regarding the best way to use the treatment, how long to use it, whether certain populations benefit more, how to balance costs, and how best to present advice and counsel to patients.
The OSN Pediatrics/Strabismus Board Members, led by Section Editor Robert S. Gold, MD, tackled this debate in a

Full Story →